
Biocept BIOC
Quartalsbericht 2023-Q2
hinzugefügt 14.08.2023
Biocept Finanzkreislauf 2011-2026 | BIOC
Finanzkreislauf Jährlich Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.1 | 29.9 | 77.9 | 192 | 124 | 55.8 | -7.1 | -2.03 | -47.1 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 192 | -47.1 | 55.7 |
Finanzkreislauf Vierteljährlich Biocept
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117 | 197 | - | 241 | 222 | 27.2 | - | 46.5 | 71.5 | 27.4 | - | 95.8 | 1.17 K | 438 | 141 | 170 | 228 | 180 | 113 | 135 | 126 | 115 | 79.6 | 69.7 | 55.4 | 10.5 | -10.7 | -8.77 | -4.74 | 12.1 | -5.97 | -3.36 | 15.1 | -15.6 | -54.4 | 17.4 | -64.7 | -99.8 | 44.6 | -187 | -205 | -109 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.17 K | -205 | 87.2 |
Finanzkreislauf anderer Aktien in der Diagnostik & Forschung
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 29.8 | -3.87 % | $ 321 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
299 | - | - | $ 79.8 M | ||
|
BioNano Genomics
BNGO
|
225 | $ 1.13 | -3.54 % | $ 1.44 M | ||
|
Castle Biosciences
CSTL
|
45.9 | - | - | $ 914 M | ||
|
Danaher Corporation
DHR
|
83.5 | $ 219.93 | 0.09 % | $ 161 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
DexCom
DXCM
|
133 | - | - | $ 26.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 209.75 | 2.09 % | $ 23.3 B | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 19.51 | -5.18 % | $ 1.05 B | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
207 | $ 11.07 | 1.37 % | $ 314 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
Exact Sciences Corporation
EXAS
|
130 | $ 103.42 | - | $ 19.2 B | ||
|
Interpace Biosciences
IDXG
|
44.9 | $ 1.82 | - | $ 7.98 M | ||
|
Lantheus Holdings
LNTH
|
90.9 | $ 67.04 | - | $ 4.64 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 23.02 | - | $ 696 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | - | -0.62 % | $ 28.7 B | ||
|
Guardant Health
GH
|
49.1 | $ 106.6 | 1.65 % | $ 13.1 B | ||
|
NeoGenomics
NEO
|
82.3 | $ 11.47 | - | $ 1.45 B | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Natera
NTRA
|
81.5 | - | -0.5 % | $ 20.7 B | ||
|
OPKO Health
OPK
|
242 | $ 1.25 | 2.05 % | $ 868 M | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Charles River Laboratories International
CRL
|
67.7 | - | -9.16 % | $ 8.49 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 32.03 | -2.72 % | $ 20 B | ||
|
IDEXX Laboratories
IDXX
|
108 | - | - | $ 53.5 B | ||
|
Illumina
ILMN
|
142 | $ 117.01 | -1.95 % | $ 18.6 B | ||
|
IQVIA Holdings
IQV
|
78 | $ 176.27 | - | $ 32 B | ||
|
Biodesix
BDSX
|
41.7 | - | - | $ 1.33 B | ||
|
Laboratory Corporation of America Holdings
LH
|
39.8 | $ 289.4 | 1.75 % | $ 24.3 B | ||
|
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 3.56 | -4.56 % | $ 1.91 M | ||
|
ICON Public Limited Company
ICLR
|
62 | - | - | $ 11 B | ||
|
Quidel Corporation
QDEL
|
68.4 | - | -3.13 % | $ 1.19 B | ||
|
Biomerica
BMRA
|
172 | $ 2.23 | - | $ 5.12 M | ||
|
Bioventus
BVS
|
208 | $ 8.04 | - | $ 504 M |